EUR 0.8
(-1.23%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 53.06 Million EUR | -37.62% |
2022 | 85.07 Million EUR | 23.46% |
2021 | 68.9 Million EUR | 15.16% |
2020 | 59.83 Million EUR | -7.3% |
2019 | 64.54 Million EUR | 75.26% |
2018 | 36.82 Million EUR | -47.27% |
2017 | 69.84 Million EUR | 86.32% |
2016 | 37.48 Million EUR | 333.42% |
2015 | 8.64 Million EUR | -38.4% |
2014 | 14.04 Million EUR | -36.13% |
2013 | 21.98 Million EUR | 11.61% |
2012 | 19.69 Million EUR | -47.37% |
2011 | 37.42 Million EUR | 77.82% |
2010 | 21.04 Million EUR | 247.8% |
2009 | 6.05 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 54.17 Million EUR | 0.0% |
2023 Q4 | 53.06 Million EUR | 0.0% |
2023 Q2 | 64.34 Million EUR | 0.0% |
2023 FY | 53.06 Million EUR | -37.62% |
2022 Q2 | 80.86 Million EUR | 0.0% |
2022 FY | 85.07 Million EUR | 23.46% |
2022 Q4 | 85.07 Million EUR | 0.0% |
2021 FY | 68.9 Million EUR | 15.16% |
2021 Q2 | 86.89 Million EUR | 0.0% |
2021 Q4 | 68.9 Million EUR | 0.0% |
2020 Q4 | 59.83 Million EUR | 0.0% |
2020 Q2 | 57.05 Million EUR | 0.0% |
2020 FY | 59.83 Million EUR | -7.3% |
2019 Q2 | 26.17 Million EUR | 0.0% |
2019 Q4 | 64.54 Million EUR | 0.0% |
2019 FY | 64.54 Million EUR | 75.26% |
2018 FY | 36.82 Million EUR | -47.27% |
2018 Q2 | 54.77 Million EUR | 0.0% |
2018 Q4 | 36.82 Million EUR | 0.0% |
2017 FY | 69.84 Million EUR | 86.32% |
2017 Q4 | 69.84 Million EUR | 0.0% |
2017 Q2 | 28.01 Million EUR | 0.0% |
2016 Q2 | 48.5 Million EUR | 0.0% |
2016 Q4 | 37.48 Million EUR | 0.0% |
2016 FY | 37.48 Million EUR | 333.42% |
2015 Q2 | 13.93 Million EUR | 0.0% |
2015 FY | 8.64 Million EUR | -38.4% |
2015 Q4 | 8.64 Million EUR | 0.0% |
2014 Q2 | 11.75 Million EUR | 0.0% |
2014 Q4 | 14.04 Million EUR | 0.0% |
2014 FY | 14.04 Million EUR | -36.13% |
2013 Q4 | 21.98 Million EUR | 0.0% |
2013 FY | 21.98 Million EUR | 11.61% |
2013 Q2 | 15.68 Million EUR | 0.0% |
2012 FY | 19.69 Million EUR | -47.37% |
2012 Q2 | 25.61 Million EUR | 0.0% |
2012 Q4 | 19.69 Million EUR | 0.0% |
2011 FY | 37.42 Million EUR | 77.82% |
2011 Q2 | 17.4 Million EUR | 0.0% |
2011 Q4 | 37.42 Million EUR | 0.0% |
2010 Q2 | 7.96 Million EUR | 0.0% |
2010 Q4 | 21.04 Million EUR | 0.0% |
2010 FY | 21.04 Million EUR | 247.8% |
2009 FY | 6.05 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Affluent Medical SA | 56.62 Million EUR | 6.277% |
Bluelinea Société Anonyme | 13.16 Million EUR | -303.115% |
Diagnostic Medical Systems S.A. | 51.13 Million EUR | -3.776% |
Euromedis Groupe | 46.25 Million EUR | -14.723% |
Eurobio Scientific Société anonyme | 315.81 Million EUR | 83.196% |
Ikonisys S.A. | 20.85 Million EUR | -154.496% |
Implanet S.A. | 10.63 Million EUR | -398.909% |
Median Technologies SA | 35.81 Million EUR | -48.188% |
SpineGuard SA | 11.03 Million EUR | -380.9% |
Theraclion SA | 18.66 Million EUR | -184.345% |
Euroapi S.A. | 1.61 Billion EUR | 96.709% |
Guerbet SA | 1.02 Billion EUR | 94.824% |